Most Patients With AD Satisfied With Baricitinib Treatment, Study Says : vimarsana.com

Based on the Likert scale, most patients with atopic dermatitis (AD) using baricitinib reported being either “satisfied” (76%) or “very satisfied” (18%).

Related Keywords

France , Germany , United Kingdom , , European Medicines Agency , Abbreviated Treatment Satisfaction Questionnaire , Itch Numerical Rating Scale , Atopic Dermatitis Treatment , Baricitinib , Itch Control , Jak Inhibitors ,